Strategic Impact of a New Academic Endocrine Surgery Program
A minority of medical centers possess a dedicated endocrine surgery program. Here we assess the short-term impact of a new endocrine surgery program on institutional case volumes and financial endpoints.
We studied all endocrine procedures performed over a 5-year period spanning the inception of the endocrine surgery program at UCLA. Institutional and state-level data on patient geographic origin, discharges for endocrine diagnosis-related groups (DRGs), and hospital-side charges and costs were examined.
Total endocrine case volume increased 112% (264 to 559 cases annually) over the study period. The relative increase was greater for parathyroid (56 to 196, 250%, P < 0.0001) and adrenal (11 to 31, 181%, P = 0.06) procedures compared to thyroid procedures (317 to 442, 39%). The endocrine case volume of nonspecialist surgeons remained stable over the study period. Growth in referrals arose from previously unrepresented zip codes and was associated with an increase in the mean distance traveled for care (2006, 44 miles vs. 2009, 92 miles, P < 0.01). In each DRG, UCLA attained the top market position within one year of the program’s inception, corresponding to an overall 27% increase in regional market share. Total hospital charges for endocrine DRGs rose 161% to $14.7 million annually, while the cost of parathyroid surgery fell 34% (P < 0.001).
The establishment of an academic endocrine surgery program can cause fundamental shifts in referral patterns within a competitive, densely populated metropolitan environment. Hospitals should consider the inclusion of an endocrine surgery program in strategic planning initiatives.
- Pasieka JL. Kindred spirits of the endocrines: the training of the future endocrine surgeons. J Surg Oncol. 2005;89:202–5. CrossRef
- Sosa JA, Wang TS, Yeo HL, et al. The maturation of a specialty: workforce projections for endocrine surgery. Surgery. 2007;142:876–83. CrossRef
- Thompson GB. The maturation of a specialty: workforce projections for endocrine surgery [editorial]. Surgery 2007;142:884–6. CrossRef
- Stavrakis AI, Ituarte PHG, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery 2007;142:887–99. CrossRef
- Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128–37. CrossRef
- Martling A, Cedarmark B, Johansson H, Rugqvist L, Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002;89:1008–13. CrossRef
- Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes for thyroidectomy. Ann Surg. 1998;228:320–30. CrossRef
- Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117–27. CrossRef
- Wijns W, Kolh PH. Experience with revascularization procedures does matter: low volume means worse outcome. Eur Heart J. 2010;31:1954–7.
- Hudorovic N, Vucetic B, Lovricevic I. The evidence for volume-outcome relationships in thoracic aortic surgery. Eur J Cardiothorac Surg. 2010;37:248–9. CrossRef
- Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747–51. CrossRef
- Finlayson EVA, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138:721–5. CrossRef
- Boudourakis LD, Roman SA, Sosa JA, Wang TS, Desai R. Evolution of the surgeon-volume, patient outcome relationship. Ann Surg. 2009;251:992. CrossRef
- Wiseman J, Mossanen M, Ituarte P, Bath J, Yeh M. An algorithm informed by the parathyroid hormone level reduces hypocalcemic complications of thyroidectomy. World J Surg. 2010;34:532–7. CrossRef
- Khuri SF. Safety, quality, and the National Surgical Quality Improvement Program. Am Surg. 2006;72:994–8.
- Consumer price index calculator. Available at: http://data.bls.gov/cgi-bin/cpicalc.pl. Accessed 29 March 2009.
- Saunders BD, Wainess RM, Dimick JB, Doherty GM, Upchurch GR, Gauger PG. Who performs endocrine operations in the United States? Surgery. 2003;134:924–31. CrossRef
- Kulkarni RP, Ituarte PHG, Gunderson D, Yeh MW. Clinical pathways improve hospital resource use in endocrine surgery. J Am Coll Surg. 2011;212:35–41. CrossRef
- Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery. 2004;136:1183–91. CrossRef
- Mitchell J, Milas M, Barbosa G, Sutton J, Berber E, Siperstein A. Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume. Surgery 2008;144:899–907. CrossRef
- Forstall RL, Greene RP, Pick JB. Which are the largest? Why lists of major urban areas vary so greatly. Tijdschr Econ Soc Geogr. 2009;100:277–97. CrossRef
- Strategic Impact of a New Academic Endocrine Surgery Program
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Annals of Surgical Oncology
Volume 18, Issue 8 , pp 2260-2264
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Author Affiliations
- 1. Endocrine Surgical Unit, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
- 2. Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA
- 3. Department of Surgery, McMaster University, Hamilton, Ontario, Canada